このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Phosphatidylserine, Taurine, and Caffeine for Cognitive Fatigue in Professional Football Players (TCPS-Foot)

2026年9月9日 更新者:Krzysztof Mizera、Vizja University in Warsaw

Neurocognitive Fatigue Resistance, Visual Search Efficiency, and Tactical Decision-Making After Phosphatidylserine-Containing Taurine-Caffeine Supplementation in Professional Male Football Players

This randomized, double-blind, placebo-controlled, parallel-group trial evaluated neurocognitive fatigue resistance and football-specific decision-making following 28 days of taurine-caffeine supplementation with or without phosphatidylserine in professional male football players. Sixty-five male outfield football players from two professional clubs were randomized to placebo, taurine plus caffeine, or taurine plus caffeine plus phosphatidylserine. Neurocognitive fatigue resistance was evaluated during a standardized high-load Stroop/Flanker task, while football-specific tactical decision-making, visual-search behavior, and field-based reactive decision performance were assessed at baseline and after 28 days of supplementation.

調査の概要

詳細な説明

This study was designed to determine whether adding phosphatidylserine to taurine-caffeine supplementation improves neurocognitive fatigue resistance and football-specific decision-making in professional male football players. Participants completed familiarization procedures, baseline laboratory and field testing, 28 days of supplementation, and post-intervention laboratory and field testing. Neurocognitive fatigue resistance was assessed using a standardized high-load Stroop/Flanker protocol. Football-specific decision-making was evaluated using video-based tactical decision tasks incorporating offensive and transitional match situations and requiring rapid selection of the most appropriate tactical response. Visual-search behavior was assessed using screen-based eye tracking during the football-specific decision task. Field-based reactive decision performance was evaluated using a standardized Reactive Passing Decision Test requiring perception of an external visual stimulus followed by selection and execution of the appropriate passing response. Outcome assessments were conducted before and after the 28-day supplementation period under standardized testing conditions.

研究の種類

介入

入学 (実際)

65

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Lodz、ポーランド
        • Professional Football Training Center
      • Warsaw、ポーランド
        • Professional Football Training Center

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人

健康ボランティアの受け入れ

はい

説明

Inclusion Criteria:

  • Male professional outfield football players aged 18 to 37 years.
  • First-team players or selected U19 players aged 18 years or older who are regularly integrated into first-team training.
  • Regular participation in club training.
  • At least 5 years of systematic football training experience.
  • Free from injury or illness limiting full participation in training and testing.
  • Normal or corrected-to-normal vision.
  • Ability to complete the laboratory and field-based testing procedures.
  • Written informed consent provided before participation.

Exclusion Criteria:

  • Goalkeepers.
  • Current injury or illness limiting full participation in testing.
  • Neurological disease.
  • Recent concussion or head trauma.
  • Uncorrected visual impairment.
  • Use of phosphatidylserine, nootropic agents, or strong stimulants during the previous 4 weeks.
  • Non-standard caffeine intake on testing days.
  • Failure to comply with pre-test standardization procedures.
  • Failed eye-tracker calibration.
  • Loss of more than 30% of gaze data during the football-specific decision-making task.
  • Withdrawal of consent.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:他の
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:4倍

武器と介入

参加者グループ / アーム
介入・治療
プラセボコンパレーター:Placebo
Participants randomized to this arm will receive an inert placebo for 28 days. The placebo will be provided in identical coded packs matched for appearance, number of units, and packaging with the active supplements.
Inert placebo matched with the active supplements for appearance, number of units, and packaging. The placebo will be administered for 28 days.
アクティブコンパレータ:Taurine Plus Caffeine
Participants randomized to this arm will receive taurine 1500 mg/day plus caffeine 200 mg/day for 28 days. On training and testing days, the supplement will be consumed approximately 60 minutes before the main training session or testing procedure. On non-training days, it will be consumed at a consistent morning time.
Taurine 1500 mg/day plus caffeine 200 mg/day administered for 28 days. On training and testing days, the supplement will be consumed approximately 60 minutes before the main training session or testing procedure. On non-training days, it will be consumed at a consistent morning time.
実験的:Taurine, Caffeine, and Phosphatidylserine
Participants randomized to this arm will receive taurine 1500 mg/day plus caffeine 200 mg/day plus phosphatidylserine 600 mg/day for 28 days. On training and testing days, the supplement will be consumed approximately 60 minutes before the main training session or testing procedure. On non-training days, it will be consumed at a consistent morning time.
Taurine 1500 mg/day plus caffeine 200 mg/day plus phosphatidylserine 600 mg/day administered for 28 days. On training and testing days, the supplement will be consumed approximately 60 minutes before the main training session or testing procedure. On non-training days, it will be consumed at a consistent morning time.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Tactical Inhibitory Decision Accuracy Under Neurocognitive Load
時間枠:Baseline and 28 days of supplementation
Tactical inhibitory decision accuracy will be assessed using football-specific video clips requiring inhibition of an immediately attractive but suboptimal tactical action. Responses will be scored as 1 point for an optimal decision, 0.5 points for an acceptable decision, and 0 points for an incorrect decision. The outcome will be calculated as the mean score across inhibitory tactical clips. The score ranges from 0 to 1, with higher values indicating better tactical inhibitory decision accuracy.
Baseline and 28 days of supplementation

二次結果の測定

結果測定
メジャーの説明
時間枠
Overall Football-Specific Optimal Decision Rate
時間枠:Baseline and 28 days of supplementation
Overall football-specific decision accuracy will be assessed using video-based offensive and transitional football situations. Players will select the most appropriate tactical option under time pressure. The outcome will be expressed as the percentage of correct or expert-rated optimal decisions, with higher values indicating better decision-making accuracy.
Baseline and 28 days of supplementation
Football-Specific Decision Time
時間枠:Baseline and 28 days of supplementation
Decision time will be assessed during the football-specific video decision-making task. It will be measured as the time taken to select a tactical response after the critical decision point. The outcome will be expressed in milliseconds, with lower values indicating faster decision-making.
Baseline and 28 days of supplementation
Impulsive Tactical Error Rate
時間枠:Baseline and 28 days of supplementation
Impulsive tactical errors will be assessed during football-specific video clips. These errors will include selections of immediately attractive but suboptimal tactical options, such as inappropriate forward actions, low-quality shots, or forced progressive decisions when a safer or more appropriate option is available.
Baseline and 28 days of supplementation
Stroop/Flanker Time-on-Task Reaction-Time Trajectory
時間枠:Baseline and 28 days of supplementation
Correct-trial reaction time will be assessed across six consecutive 5-minute epochs of the 30-minute high-load Stroop/Flanker task. Time-on-task performance decrement will be quantified from the within-session trajectory of reaction time across successive epochs, with a greater increase in reaction time indicating greater neurocognitive performance deterioration and a smaller increase indicating greater neurocognitive fatigue resistance. Response accuracy across epochs will be reported as a complementary measure.
Baseline and 28 days of supplementation
Stroop/Flanker Reaction-Time Variability
時間枠:Baseline and 28 days of supplementation
Reaction-time variability will be assessed during the 30-minute high-load Stroop/Flanker task. It will be quantified from valid correct-trial reaction times as a within-participant measure of response-time variability and expressed in milliseconds, with greater variability indicating lower response stability.
Baseline and 28 days of supplementation
Post-Task Mental Fatigue
時間枠:Baseline and 28 days of supplementation
Perceived mental fatigue will be assessed immediately before and immediately after the 30-minute neurocognitive-load task using a 0-10 numerical rating scale, with higher scores indicating greater perceived mental fatigue. The registered outcome will be the post-task mental-fatigue score assessed at baseline and after 28 days of supplementation. The acute pre-to-post task change will additionally be used as a manipulation check of the neurocognitive-load protocol.
Baseline and 28 days of supplementation
Time to First Fixation on the Optimal Tactical Area of Interest
時間枠:Baseline and 28 days of supplementation
Time to first fixation on the optimal tactical option will be assessed using screen-based eye-tracking during the football-specific video decision-making task. The outcome will be expressed in milliseconds and will reflect how quickly the player visually orients toward the expert-defined optimal option.
Baseline and 28 days of supplementation
Dwell Time on the Optimal Tactical Area of Interest
時間枠:Baseline and 28 days of supplementation
Dwell time on the optimal tactical option will be assessed using screen-based eye-tracking during the football-specific video decision-making task. The outcome will be expressed as the percentage of total viewing time spent fixating on the expert-defined optimal tactical option.
Baseline and 28 days of supplementation
Situational-Awareness Accuracy
時間枠:Baseline and 28 days of supplementation
Situational awareness accuracy will be assessed using probes presented after selected football-specific video clips. These probes will evaluate whether players correctly identified key tactical information, including available space, pressure location, number of defenders, teammate positioning, and defensive-line configuration.
Baseline and 28 days of supplementation
Reactive Passing Decision-Selection Accuracy
時間枠:Baseline and 28 days of supplementation
Reactive Passing Decision Test accuracy will be assessed during a field-based football-specific task. Players will dribble into a decision zone and respond to a late visual or situational cue by selecting and executing the optimal passing option. The outcome will be expressed as the percentage of accurate decisions.
Baseline and 28 days of supplementation

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年8月6日

一次修了 (実際)

2026年9月8日

研究の完了 (実際)

2026年9月8日

試験登録日

最初に提出

2026年7月5日

QC基準を満たした最初の提出物

2026年7月5日

最初の投稿 (実際)

2026年7月10日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月14日

QC基準を満たした最後の更新が送信されました

2026年9月9日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

No individual participant data will be shared because the study includes a small sample of professional football players from a limited number of clubs, which may increase the risk of indirect participant identification. Only aggregated and anonymized study results will be reported.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する